Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/180605
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Oncolytic viruses (OVs) preferentially infect and selectively replicate in cancer cells. OVs have been tested in clinical trials as monotherapy or in combination with chemotherapy, radiotherapy, and immunotherapy. However, the dense extracellular matrix hampers the intratumoral spreading and efficacy of OVs. Previously we described VCN-01, an oncolytic adenovirus expressing a soluble version of human sperm hyaluronidase (hyal) PH20, which exhibited enhanced intratumoral distribution and antitumor activity in different models. Here, we present two oncolytic adenoviruses designed to increase the secretion of PH20 compared to VCN-01. ICO15K-40SAPH20, encoding PH20 under an Ad40 splice acceptor, and ICO15K-E1aPH20 expressing PH20 fused to the E1A gene by P2A peptide. We demonstrate that increased hyal activity improves antitumor efficacy in both a sensitive immunodeficient model and an immunocompetent model. Moreover, we show that hyal activity impacts T cell accumulation in tumors, highlighting the value of a hyaluronidase-expressing virus for combinations with other immunotherapies in cancers involving dense stroma.
Matèries
Matèries (anglès)
Citació
Citació
FARRERA SAL, Martí, MORENO, Rafael, MATO BERCIANO, Ana, MALIANDI, María victoria, BAZAN PEREGRINO, Miriam, ALEMANY, Ramon. Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation. _Molecular Therapy - Oncolytics_. 2021. Vol. 22, núm. 27-35. [consulta: 24 de gener de 2026]. ISSN: 2372-7705. [Disponible a: https://hdl.handle.net/2445/180605]